Cognixion is launching a clinical trial to test its noninvasive brain-computer interface (BCI) technology, which is integrated with the Apple Vision Pro, to help paralyzed individuals communicate through their thoughts by replacing the traditional headband with a device that collects brain data from the visual and parietal cortex.

This innovative system leverages the capabilities of the Vision Pro to facilitate communication without physical movement, focusing on users with severe motor disabilities.

Unlike invasive options like Neuralink, Cognixion's approach is noninvasive, using a custom EEG headband with sensors and AI software to interpret brain signals, aiming for wider accessibility and faster deployment.

The BCI system uses AI to personalize interpretation of brain signals, particularly visual fixation signals, enabling menu selection through mental attention, with alternative controls such as eye tracking and head movement.

Experts recognize the potential of noninvasive BCIs but note challenges like weaker, noisier signals, which AI advancements are expected to help overcome, making these solutions more practical and accessible.

The company aims to demonstrate the safety and efficacy of its system through larger pivotal trials, with regulatory approval contingent on showing improved quality of life and user-friendliness for severely disabled users.

Apple’s recent protocol updates have created opportunities for BCI integration with its devices, although Apple itself is not developing a BCI, and other companies like Synchron are also exploring similar technologies.